세일즈 담당자와 상담 받으세요.
상담하기
Lunit
KO
EN
제품 문의하기
루닛은 증거에 기반한 AI를 개발합니다.
루닛의 연구 결과
Latest
Latest
AI
Breast
Chest
Oncology
REFERENCE LIBRARY
Clear Filters
Journal of Clinical Oncology
Lancet Digital Health
JAMA Oncology
Radiology
Clinical Cancer Research
European Journal of Cancer
CVPR
ICCV
ECCV
MICCAI
NeurIPS
ICLR
Others
Publications
Breast
Mammography Breast Cancer Screening Triage Using Deep Learning: A UK Retrospective Study
AUTHOR
Sarah E. Hickman et al.
PUBLICATION
Radiology 2023
Read More
Oncology
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer
AUTHOR
Yoojoo Lim et al.
PUBLICATION
npj Precision Oncology 2023
Read More
Breast
Population-wide evaluation of artificial intelligence and radiologist assessment of screening mammograms
AUTHOR
Johanne Kühl1 et al.
PUBLICATION
European Radiology (2023)
Read More
Oncology
Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study
AUTHOR
Keun-Wook Lee et al.
PUBLICATION
SITC 2023
Read More
Oncology
AI-powered immune phenotyping based on programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) in triple negative breast cancer (TNBC)
AUTHOR
Sangwon Shin et al.
PUBLICATION
SITC 2023
Read More
Fragmented pattern of tumor mass is related to fibroblast activation mitigating spatial interaction between tumor and immune cells
AUTHOR
Sukjun Kim et al.
PUBLICATION
SITC 2023
Read More
Oncology
Pan-cancer methylation analysis reveals a significant correlation of immune-desert phenotype with methylation aberrancy
AUTHOR
Sanghoon Song et al.
PUBLICATION
SITC 2023
Read More
Oncology
Tumor-infiltrating lymphocytes in tumor microenvironment assessed by AI-powered H&E image analyzer is correlated with immunomodulatory subtype of triple-negative breast cancer
AUTHOR
Jimin Moon et al.
PUBLICATION
SITC 2023
Read More
Oncology
Spatial analysis of tumor-infiltrating lymphocytes in tumor microenvironment in non-small cell lung cancer patients who have resistance after EGFR tyrosine kinase inhibitors
AUTHOR
Yeong Hak Bang et al.
PUBLICATION
SITC 2023
Read More
Oncology
2330P - Pre-test prediction of multiple druggable mutations based on H&E image artificial intelligence (AI) analysis may enable more efficient clinical workflow...
AUTHOR
Junho Lee et al.
PUBLICATION
ESMO 2023
Read More
1
2
3
4
5